Anaptysbio (ANAB) Change in Cash (2016 - 2026)

Anaptysbio (ANAB) has 11 years of Change in Cash data on file, last reported at $10.3 million in Q1 2026.

• Quarterly Change in Cash rose 142.03% year-over-year to $10.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $149.8 million (up 233.39% YoY) and the FY2025 annual result came in at $115.1 million, up 32.14% from the prior year.
• Change in Cash eased to $10.3 million in Q1 2026, from $128.4 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $128.4 million in Q4 2025 to a low of -$329.3 million in Q1 2022.
• A 5-year average of -$14.5 million and a median of $9.7 million in 2023 frame the typical range for Change in Cash.
• Annual changes were most pronounced in 2022 — Change in Cash slumped 1077.43% — and 2024, when it surged 1443.96%.
• Tracing ANAB's Change in Cash over 5 years: stood at $12.8 million in 2022, then slipped by 24.22% to $9.7 million in 2023, then plunged by 808.39% to -$68.5 million in 2024, then soared by 287.39% to $128.4 million in 2025, then slumped by 92.0% to $10.3 million in 2026.
• The last three Change in Cash figures came in at $10.3 million (Q1 2026), $128.4 million (Q4 2025), and $65.5 million (Q3 2025), per Business Quant data.